Compare AMP & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMP | COR |
|---|---|---|
| Founded | 1894 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.3B | 59.9B |
| IPO Year | 2009 | 2001 |
| Metric | AMP | COR |
|---|---|---|
| Price | $552.46 | $328.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 14 |
| Target Price | ★ $544.91 | $390.62 |
| AVG Volume (30 Days) | 339.1K | ★ 1.3M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.43% | 0.77% |
| EPS Growth | ★ 9.77 | 5.71 |
| EPS | ★ 21.64 | 15.21 |
| Revenue | $18,911,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $1.79 | $8.89 |
| Revenue Next Year | $4.20 | $6.75 |
| P/E Ratio | $25.56 | ★ $21.28 |
| Revenue Growth | 5.49 | ★ 9.31 |
| 52 Week Low | $422.37 | $244.82 |
| 52 Week High | $572.56 | $377.54 |
| Indicator | AMP | COR |
|---|---|---|
| Relative Strength Index (RSI) | 47.25 | 60.35 |
| Support Level | $489.57 | $299.49 |
| Resistance Level | $550.18 | $333.95 |
| Average True Range (ATR) | 10.11 | 6.45 |
| MACD | -3.60 | 0.01 |
| Stochastic Oscillator | 0.00 | 90.29 |
Ameriprise Financial has evolved into a diversified financial services provider that generates roughly 65% of its operating profit from advice and wealth management. With nearly $1.2 trillion in segment assets under management and advisory at year-end 2025, and with roughly 10,600 affiliated and employee advisors, Ameriprise is one of the larger US-based wealth managers. It also boasts a reasonably large asset management franchise in Columbia Threadneedle, which boasted $678 billion in assets under management at year-end 2025. The firm's third segment is its retirement and protection services business, which sells insurance products to the firm's advisory clients. After eliminations, Ameriprise had $1.69 trillion in assets under management and advisory across segments at year-end 2025.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.